Alpha-defensin as a Diagnostic Means to Distinguish Between Acute Bacterial and Viral Infections

• Conditions: Viral Infection; Bacterial Infections
• Interventions: Diagnostic Test: Laboratory blood test

• Registration Number: NCT03846921
• Lead Sponsor: Hillel Yaffe Medical Center

Brief Summary

This study aims to investigate the use of alpha-defensin as a diagnostic means to distinguish between acute bacterial and viral infections.

Detailed Description

Not available

Study Timeline

• Status Verified: 2019-02
• Study First Submitted: 2019-02-18
• Study First Submitted QC: 2019-02-18
• Study First Posted: 2019-02-20
• Study Start: 2019-03-04
• Last Update Submitted: 2019-03-06
• Last Update Posted: 2019-03-08
• Primary Completion: 2020-03
• Study Completion: 2020-03

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Children with either bacterial or viral infections

Exclusion Criteria

• All others

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Bacterial Infection	Laboratory blood test	Patients with proven bacterial infections will have laboratory blood test taken
Viral infection	Laboratory blood test	Patients with proven viral infections will have laboratory blood test taken

Primary Outcome Measures

Name	Time	Method
Rise in alpha-defensin	One year	Laboratory blood tests will be analyzed to determine whether there is a rise in alpha-defensin levels in bacterial infections as compared to viral infections.

Trial Locations

Locations (1)

Hillel Yaffe Medical Center; 🇮🇱 Hadera, Israel